Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Pancreatic cancer
Closed
Phase 3
This trial is comparing a new drug called Acelarin with gemcitabine for people with pancreatic cancer. It is for people whose cancer has spread elsewhere in the body (metastatic pancreatic cancer). This trial is supported by Cancer Research UK.
Recruitment start: 26 November 2015
Recruitment end: 9 June 2021
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Daniel Palmer
Cancer Research UK
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
NuCana Biomed Ltd
The Clatterbridge Cancer Centre NHS Foundation Trust.
This is Cancer Research UK trial number CRUKE/15/013
Last reviewed: 18 May 2022
CRUK internal database number: 13343
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
